Insider · CIK 0001102900
Lance Berberian
officer
Files at LH (LABCORP HOLDINGS INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | LH LABCORP HOLDINGS INC. | AGrant or award Common Stock | +3,325 | $0.00 | $0 | 20,005 | Mar 31, 2025 |
| Mar 27, 2025 | LH LABCORP HOLDINGS INC. | FTax withholding Common Stock | -1,353 | $231.67 | $313k | 18,652 | Mar 31, 2025 |
| Feb 11, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Common Stock | +323 | - | - | 16,766 | Feb 13, 2025 |
| Feb 11, 2025 | LH LABCORP HOLDINGS INC. | FTax withholding Common Stock | -86 | $245.14 | $21k | 16,680 | Feb 13, 2025 |
| Feb 11, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Restricted Stock Unitderivative | -323 | $0.00 | $0 | 1,067 | Feb 13, 2025 |
| Feb 6, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Common Stock | +356 | - | - | 16,277 | Feb 10, 2025 |
| Feb 6, 2025 | LH LABCORP HOLDINGS INC. | FTax withholding Common Stock | -94 | $247.74 | $23k | 16,183 | Feb 10, 2025 |
| Feb 7, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Common Stock | +354 | - | - | 16,537 | Feb 10, 2025 |
| Feb 7, 2025 | LH LABCORP HOLDINGS INC. | FTax withholding Common Stock | -94 | $246.27 | $23k | 16,443 | Feb 10, 2025 |
| Feb 6, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Restricted Stock Unitderivative | -356 | $0.00 | $0 | 1,744 | Feb 10, 2025 |
| Feb 7, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Restricted Stock Unitderivative | -354 | $0.00 | $0 | 1,390 | Feb 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.